Effektivnost' teriflunomida u patsientov s vpervye diagnostirovannym retsidivirujuschim rassejannym sklerozom v issledovanijah TEMSO i TOWER po rezul'tatam aposteriornogo analiza

Wolinsky J.S.

Nauchnyĭ tsentr zdorovja pri Tehasskom universitete v Hjustone, Hjuston, shtat Tehas, SShA

Freedman M.S.

Comi G.

Universitet Vita-Salute San Raffaele, Milan, Italija

Bouchard J.P.

Universitet Laval, Centre Hopitalier Universitaire de Québec, Kvebek, provintsija Kvebek, Kanada

Kappos L.

Nevrologicheskoe otdelenie i tsentr rasseiannogo skleroza, Kantongospital' Bazelia, Shveĭtsariia

Truffinet P.

Genzyme, kompanija Sanofi, Shiĭi-Mazaren, Frantsija

Thangavelu K.

Genzyme, kompanija Sanofi, Kembridzh, shtat Massachusets, SShA

Cavalier S.

Genzyme, kompanija gruppy Sanofi, Kembridzh, Massachusets, SShA

O’Connor P.

Universitet Toronto, Toronto, shtat Ontario, Kanada

Effektivnost' teriflunomida u patsientov s vpervye diagnostirovannym retsidivirujuschim rassejannym sklerozom v issledovanijah TEMSO i TOWER po rezul'tatam aposteriornogo analiza

Authors:

Wolinsky J.S., Freedman M.S., Comi G., Bouchard J.P., Kappos L., Truffinet P., Thangavelu K., Cavalier S., O’Connor P.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(8‑2): 101‑101

Downloaded: 4

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Wolinsky JS, Freedman MS, Comi G, et al. . Effektivnost' teriflunomida u patsientov s vpervye diagnostirovannym retsidivirujuschim rassejannym sklerozom v issledovanijah TEMSO i TOWER po rezul'tatam aposteriornogo analiza. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(8‑2):101‑101. (In Russ.)